OP 5.3 - 00082 1-year treatment with ponatinib provides protection of CD4+T cells against HIV that is maintained at least 1 year more after treatment interruption

• Main Authors: M. Manzanares (Author), F. Ramos-Martín (Author), G. Casado-Fernández (Author), M. Torres (Author), E. Mateos (Author), L. Vigón (Author), S. Rodríguez-Mora (Author), V. García-Gutiérrez (Author), V. Planelles (Author), M. Coiras (Author)
• Format: Book
• Published: Elsevier, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.